58. Baker AW, Durkin MJ, Dicks KV, Lewis SS, Moehring RW, Chen LF, et al. Methicillin‐resistant Staphylococcus aureus bloodstream infection surveillance: National Healthcare Safety Network's laboratory‐identified event reporting versus traditional laboratory‐confirmed bloodstream infection surveillance. Infect Control Hosp Epidemiol. 2014;35(10):1286‐9 https://doi.org/10.1086/678071. 59. Blot K, Hammami N, Blot S, Vogelaers D, Lambert ML. Seasonal variation of hospital‐acquired bloodstream infections: A national cohort study. Infect Control Hosp Epidemiol. 2021:1‐7 https://doi.org/10.1017/ice.2021.85. 60. Gubbels S, Nielsen J, Voldstedlund M, Kristensen B, Schonheyder HC, Ellermann‐Eriksen S, et al. National Automated Surveillance of Hospital‐Acquired Bacteremia in Denmark Using a Computer Algorithm. Infect Control Hosp Epidemiol. 2017;38(5):559‐66 https://doi.org/10.1017/ice.2017.1. 61. Ridgway JP, Sun X, Tabak YP, Johannes RS, Robicsek A. Performance characteristics and associated outcomes for an automated surveillance tool for bloodstream infection. Am J Infect Control. 2016;44(5):567‐71 https://doi.org/10.1016/j.ajic.2015.12.044. 62. Altorf‐van der Kuil W, Schoffelen AF, de Greeff SC, Thijsen SF, Alblas HJ, Notermans DW, et al. National laboratory‐based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands. Euro Surveill. 2017;22(46) https://doi.org/10.2807/1560‐7917.ES.2017.22.46.17‐00062. 63. Dantes RB, Rock C, Milstone AM, Jacob JT, Chernetsky‐Tejedor S, Harris AD, Leekha S. Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare‐associated infection outcome measure. Infect Control Hosp Epidemiol. 2019;40(3):358‐61 https://doi.org/10.1017/ice.2018.339. 64. Dantes RB, Abbo LM, Anderson D, Hall L, Han JH, Harris AD, et al. Hospital epidemiologists' and infection preventionists' opinions regarding hospital‐onset bacteremia and fungemia as a potential healthcare‐associated infection metric. Infect Control Hosp Epidemiol. 2019;40(5):536‐40 https://doi.org/10.1017/ice.2019.40. 65. Khanafer N, Allaouchiche B, Argaud L, Lepape A, Guerin C, Girard R, et al. Risk factors for nosocomial bacteraemia in intensive care units vary depending on causative agents: results of a prospective surveillance study from 2003 to 2006. J Hosp Infect. 2011;79(2):184‐5 https://doi.org/10.1016/j.jhin.2011.04.030. 66. Ginter K, Schwab F, Behnke M, Wolkewitz M, Gastmeier P, Geffers C, Maechler F. SAPS2, APACHE2, SOFA, and Core‐10‐TISS upon admission as risk indicators for ICU‐acquired infections: a retrospective cohort study. Infection. 2023 https://doi.org/10.1007/s15010‐022‐01972‐y. 67. Plantinga NL, de Smet A, Oostdijk EAN, de Jonge E, Camus C, Krueger WA, et al. Selective digestive and oropharyngeal decontamination in medical and surgical ICU patients: individual patient data meta‐ analysis. Clin Microbiol Infect. 2018;24(5):505‐13 https://doi.org/10.1016/j.cmi.2017.08.019. 68. Decoster A, Grandbastien B, Demory MF, Leclercq V, Alfandari S, Regional Network 'Review of nosocomial infection‐related m. A prospective study of nosocomial‐infection‐related mortality assessed through mortality reviews in 14 hospitals in Northern France. J Hosp Infect. 2012;80(4):310‐5 https://doi.org/10.1016/j.jhin.2011.11.016. 69. Baines RJ, Langelaan M, de Bruijne MC, Wagner C. Is researching adverse events in hospital deaths a good way to describe patient safety in hospitals: a retrospective patient record review study. BMJ Open. 2015;5(7):e007380 https://doi.org/10.1136/bmjopen‐2014‐007380. 70. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003;54(4):258‐66 https://doi.org/10.1016/s0195‐6701(03)00150‐6. 256 Chapter 10
RkJQdWJsaXNoZXIy MTk4NDMw